Itoco Inc. (ITMC)
USD 0.01
(177.78%)
USD 0.01
(177.78%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | 1.4 Million USD | 76364.88% |
| 2021 | 1831.00 USD | -98.1% |
| 2020 | 96.26 Thousand USD | 317.99% |
| 2019 | 23.02 Thousand USD | 2159.96% |
| 2018 | 1019.00 USD | -96.7% |
| 2017 | 30.88 Thousand USD | 64252.08% |
| 2016 | 48.00 USD | -99.72% |
| 2015 | 17.1 Thousand USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2009 | 3.28 Million USD | 8226.06% |
| 2008 | 39.4 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q1 | 1.33 Million USD | -5.0% |
| 2023 Q2 | 1.26 Million USD | -5.26% |
| 2023 Q3 | 1.19 Million USD | -5.56% |
| 2022 Q1 | 45.92 Thousand USD | 107.46% |
| 2022 Q3 | 3.92 Million USD | 12680.68% |
| 2022 FY | 1.4 Million USD | 76364.88% |
| 2022 Q4 | 1.4 Million USD | -64.29% |
| 2022 Q2 | 30.67 Thousand USD | -33.2% |
| 2021 Q1 | 281.13 Thousand USD | 0.0% |
| 2021 FY | 1831.00 USD | -98.1% |
| 2021 Q4 | 22.13 Thousand USD | -79.47% |
| 2021 Q3 | 107.83 Thousand USD | -32.65% |
| 2021 Q2 | 160.11 Thousand USD | -43.05% |
| 2020 FY | 96.26 Thousand USD | 317.99% |
| 2019 FY | 23.02 Thousand USD | 2159.96% |
| 2018 FY | 1019.00 USD | -96.7% |
| 2017 FY | 30.88 Thousand USD | 64252.08% |
| 2016 FY | 48.00 USD | -99.72% |
| 2015 FY | 17.1 Thousand USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2010 Q2 | 2.01 Million USD | -40.19% |
| 2010 Q3 | 1.91 Million USD | -4.84% |
| 2010 Q1 | 3.36 Million USD | 2.56% |
| 2009 FY | 3.28 Million USD | 8226.06% |
| 2009 Q4 | 3.28 Million USD | -31.12% |
| 2009 Q3 | 4.76 Million USD | 57248.93% |
| 2009 Q2 | 8305.00 USD | -65.51% |
| 2009 Q1 | 24.08 Thousand USD | -38.88% |
| 2008 Q1 | 69.16 Thousand USD | 0.0% |
| 2008 Q2 | 59.81 Thousand USD | -13.52% |
| 2008 Q4 | 39.4 Thousand USD | 0.0% |
| 2008 FY | 39.4 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 10.55 Million USD | 86.734% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -81.676% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -153.581% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -191.344% |
| Qrons Inc. | 420.00 USD | -333250.476% |
| Rebus Holdings, Inc. | 5000.00 USD | -27901.44% |
| Skye Bioscience, Inc. | 11.94 Million USD | 88.275% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 98.925% |
| Adynxx, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | 94.99% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -103.651% |
| Arch Therapeutics, Inc. | 1.95 Million USD | 28.502% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -60509.177% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 96.396% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | 80.608% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -1733.659% |
| SQZ Biotechnologies Company | 107.18 Million USD | 98.694% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | 2.232% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -1834.736% |
| Mesoblast Limited | 667.9 Million USD | 99.79% |
| Marizyme, Inc. | 22.01 Million USD | 93.64% |
| Genus plc | 1.02 Billion USD | 99.864% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -3.071% |
| Pharming Group N.V. | 462.85 Million USD | 99.698% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | 57.74% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -180.554% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -123.297% |
| ContraFect Corporation | 20.67 Million USD | 93.229% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -258.656% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -266.341% |
| IMV Inc. | 31.33 Million USD | 95.532% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | 66.231% |
| MultiCell Technologies, Inc. | 126.22 USD | -1109131.501% |
| ONE Bio Corp. | 70.08 Million USD | 98.002% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -48.993% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 98.911% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -224.305% |
| Q BioMed Inc. | 3.51 Million USD | 60.175% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 96.02% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -435.857% |
| Biomind Labs Inc. | 73.81 Thousand USD | -1796.628% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 99.686% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | 3.366% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | 95.335% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | 49.02% |
| Curative Biotechnology, Inc. | 2.6 Million USD | 46.217% |
| GB Sciences, Inc. | 103.44 Thousand USD | -1253.485% |
| Alpha Cognition Inc. | 2.45 Million USD | 42.905% |
| HST Global, Inc. | 1526.00 USD | -91647.837% |
| CSL Limited | 38.02 Billion USD | 99.996% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -41.712% |
| Halberd Corporation | 10.13 Thousand USD | -13719.682% |
| Enzolytics Inc. | 361.7 Million USD | 99.613% |
| Agentix Corp. | 261.39 Thousand USD | -435.622% |
| Resverlogix Corp. | 8.11 Million USD | 82.747% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | 25.444% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 99.969% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 97.065% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -118.879% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -6045.788% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | 84.355% |
| AVAX Technologies, Inc. | 7.37 Million USD | 81.022% |
| Zenith Capital Corp. | 7410.00 USD | -18794.359% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.959% |
| Ember Therapeutics, Inc. | 184.00 USD | -760808.696% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -335.067% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -435.679% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -50.876% |
| Kadimastem Ltd | 2.3 Million USD | 39.235% |
| Helix BioMedix, Inc. | 3.02 Million USD | 53.718% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 97.343% |
| BioStem Technologies, Inc. | 14.56 Million USD | 90.384% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -2352.223% |
| LadRx Corporation | 2.3 Million USD | 39.335% |
| Cell Source, Inc. | 195.17 Thousand USD | -617.357% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -295.929% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -295.929% |
| NovAccess Global Inc. | 62.24 Thousand USD | -2149.184% |
| Affymax, Inc. | 7.44 Million USD | 81.189% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -1363.638% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -1220.823% |
| Mobile Lads Corp. | 52.00 USD | -2692346.154% |
| CytoDyn Inc. | 11.13 Million USD | 87.428% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -879.263% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -7730.38% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -263.211% |
| SYBLEU INC | 330.46 Thousand USD | -323.663% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -241.963% |
| International Stem Cell Corporation | 5.39 Million USD | 74.025% |
| Bioxytran, Inc. | 137.63 Thousand USD | -917.213% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | 90.667% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | 91.555% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -1672.243% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -61.918% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | 81.375% |
| Neutra Corp. | 2851.00 USD | -49008.102% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 95.68% |
| PureTech Health plc | 693.97 Million USD | 99.798% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | 82.653% |
| IXICO plc | 15.84 Million USD | 91.163% |
| IntelGenx Technologies Corp. | 8.28 Million USD | 83.095% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 98.645% |
| CSL Limited | 38.02 Billion USD | 99.996% |
| Cellectis S.A. | 333.99 Million USD | 99.581% |